Pacific Biosciences of California Inc (PACB)


Stock Price Forecast

March 15, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Pacific Biosciences of California Inc chart...

About the Company

pacbio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. we provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges. our strength comes from the dedication of our people, who are fueled by a desire to effect real, positive change. with a focus on the future and an experienced, passionate team, we are motivated to continue to redefine what is possible in genomics.

Exchange

NASDAQ

Website

pacificbiosciences.com

$200M

Total Revenue

699

Employees

$1B

Market Capitalization

-3.08

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $PACB News

Director David Meline Acquires 40,000 Shares of Pacific Biosciences of California Inc (PACB)

12d ago, source: Yahoo Finance

Pacific Biosciences of California Inc (NASDAQ:PACB), a company specializing in developing and manufacturing sequencing systems to resolve genetically complex problems, has reported an insider purchase ...

Pacific Biosciences (PACB) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

1mon ago, source: Zacks.com on MSN

For the quarter ended December 2023, Pacific Biosciences of California (PACB) reported revenue of $58.36 million, up 113.4% over the same period last year. EPS came in at -$0.27, compared to -$0.35 in ...

PacBio's (PACB) New Panel to Aid Its Clinical Research Solution

5d ago, source:

PacBio (PACB) announces the PureTarget repeat expansion panel, which is the HiFi long-read sequencing that supports comprehensive analysis of 20 genes associated with neurological diseases.

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March

11d ago, source:

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a ...

11 Oversold NASDAQ Stocks To Buy Right Now

5d ago, source: Yahoo Finance

ARK Investment Management was the largest shareholder in Pacific Biosciences of California (NASDAQ:PACB) at the end of the ...

Announcing the San Francisco Business Times 40 Under 40 class of 2024

14d ago, source:

We will profile the full 40 Under 40 class of 2024 in a special edition of the paper and celebrate them at a gala evening April 25 in San Francisco. Edreece Arghandiwal, Oakland Roots & Soul SC, chief ...

California primary results: Irwin out front in state Assembly District 42

on MSN ago, source:

Irwin's lead was narrower within Ventura County, where she led with 50.25% of 83,597 votes in the county's share of the ...

Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System

10d ago, source: Business Wire

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX Nanosecond Pulsed Field ...

Smartphone brand Xiaomi to launch first electric car in March

6d ago, source: DPA International on MSN

Shortly after Apple gave up on its plans to build an electric car, rival smartphone manufacturer Xiaomi has announced that ...

Gene Expression Analysis Market 2024, Size, Growth, Industry Trends, And Forecast By 2032

3d ago, source: Mena FN

According to the latest report by IMARC Group, titled“ Gene Expression Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,” provides an extensive analysis ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...